ASCENDIS PHARMA AS

NASDAQ: ASND (Ascendis Pharma A/S)

Last update: 24 Jun, 6:06PM

179.10

3.32 (1.89%)

Previous Close 175.78
Open 176.00
Volume 283,535
Avg. Volume (3M) 500,487
Market Cap 10,834,511,872
Price / Sales 23.48
52 Weeks Range
111.09 (-37%) — 183.00 (2%)
Earnings Date 1 Sep 2025 - 5 Sep 2025
Profit Margin -92.67%
Operating Margin (TTM) -103.23%
Diluted EPS (TTM) -6.86
Quarterly Revenue Growth (YOY) 5.30%
Current Ratio (MRQ) 1.04
Operating Cash Flow (TTM) -218.93 M
Levered Free Cash Flow (TTM) -133.44 M
Return on Assets (TTM) -22.39%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Ascendis Pharma A/S Bullish Bullish

AIStockmoo Score

-0.5
Analyst Consensus 4.0
Insider Activity NA
Price Volatility -4.0
Technical Moving Averages -2.5
Technical Oscillators 0.5
Average -0.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ASND 11 B - - -
MTSR 3 B - - 6.12
DNTH 606 M - - 1.84
BCYC 515 M - - 0.660
MAZE 504 M - 164.29 1.82
RAPP 439 M - - 1.54

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 0.78%
% Held by Institutions 113.57%
52 Weeks Range
111.09 (-37%) — 183.00 (2%)
Price Target Range
200.00 (11%) — 280.00 (56%)
High 280.00 (Evercore ISI Group, 56.34%) Buy
Median 220.00 (22.84%)
Low 200.00 (Cantor Fitzgerald, 11.67%) Buy
Average 229.63 (28.21%)
Total 8 Buy
Avg. Price @ Call 170.10
Firm Date Target Price Call Price @ Call
Morgan Stanley 03 Jul 2025 250.00 (39.59%) Buy 174.18
05 May 2025 250.00 (39.59%) Buy 170.74
Oppenheimer 13 Jun 2025 224.00 (25.07%) Buy 170.80
B of A Securities 09 Jun 2025 216.00 (20.60%) Buy 173.15
03 Jun 2025 201.00 (12.23%) Buy 174.40
Cantor Fitzgerald 12 May 2025 200.00 (11.67%) Buy 154.43
Evercore ISI Group 02 May 2025 280.00 (56.34%) Buy 172.06
JP Morgan 02 May 2025 245.00 (36.80%) Buy 172.06
RBC Capital 02 May 2025 210.00 (17.25%) Buy 172.06
16 Apr 2025 205.00 (14.46%) Buy 158.15
Wedbush 02 May 2025 212.00 (18.37%) Buy 172.06
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria